Other News In 1994
1994
AZT is Found to Protect Newborns from HIV
HRSA Launches Massive Effort to Disseminate Findings
Findings from the AIDS Clinical Trial Group (ACTG) 076 demonstrated that with a particular regimen of AZT (zidovudine), the incidence of perinatal HIV transmission plummeted from 22.6 to 7.6 percent. This finding may represent the most significant victory in the prevention of HIV/AIDS since the discovery that HIV is transmitted through bodily fluids.
In response to ACTG 076, the U.S. Public Health Service convened a workshop June 6-7, 1994, in Bethesda, Maryland. Recommendations for the use of the regimen in women and infants were developed and published in August 1994.
The following year, in 1995, HRSA issued a major program advisory entitled “Use of Zidovudine to Reduce Perinatal HIV Transmission in HRSA Funded Programs,” which detailed strategies for carrying out Public Health Service recommendations.
HRSA Program Advisory Has Immediate Impact
“HRSA’s program advisory regarding reduction in perinatal HIV transmission by use of zidovudine during pregnancy and delivery and in the postnatal period ensured that PHS recommendations were rapidly disseminated to HRSA-funded grantees and clinical providers. During the subsequent 2 years, as the PHS recommendations were adopted by HRSA-funded and other clinical care givers, a substantial decrease in mother-to-child transmission rates was documented by the Centers for Disease Control and Prevention and state health departments.” Bowen SG. Personal Communication. January 23, 2007.
—G. Stephen Bowen,
Director
The Bureau of Health Resources Development, HRSA
at the time of ACTG 076
-
Toward Passage - 1986
HRSA Debuts First
AIDS Program - 1987
AZT Reimbursement
Program Launches - 1988
Pediatric AIDS
Grants Begins - 1989
HRSA Funds Move
Outside Epicenters - 1990
CARE Act Is Adopted,
Named for Indiana Teen -
The Early Years - 1991
HRSA Awards First
CARE Act Grants - 1992
Training Creates Access
to Expert Care - 1993
Largest Epicenters
Now Number 25 - 1994
AZT Is Found to Protect
Newborns From HIV - 1995
The Age of Combination
Therapy Arrives -
Adapting to Change - 1996
CARE Act
Reauthorized - 1997
Programs Unite
Under One Umbrella - 1998
Administration Addresses
Epidemic in Minorities - 1999
Minority AIDS Initiative
is Launched - 2000
Reauthorization Focuses
on People Not in Care -
A New Millennium - 2001
HRSA Publishes Treatment
Guide for Women - 2002
CARE Act Expertise
Goes Global - 2003
Global HIV/AIDS
Program Begins - 2004
HRSA Addresses
Severity of Need - 2005
New Treatment
for Addiction -
New Approaches - 2006
The CARE Act
Makeover - 2007
New Policies—
Waves of Change - 2008
Continuing Work
on Re-entry Programs - 2009
Improving
Performance Data - 2010
20 Years and
a Legacy of Care -
The Road Ahead - 2011
30 Years of AIDS:
Honoring the Past,
Looking Toward the Future - 2012
Care is Prevention